| Title | Global Viral Vector & Plasmid DNA Manufacturing Market worth $12.8 billion by 2028 |
|---|
| URL | https://www.bloomberg.com/press-releases/2023-06-12/viral-vector-manufacturing-market-worth-12-8-billion-marketsandmarkets |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | Viral Vector Manufacturing Market |
|---|
| Meta Description | Viral Vector Manufacturing Market, Plasmid DNA Manufacturing Market, Viral Vector Manufacturing Market Size, Viral Vector Manufacturing Market Growth |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The Global Viral Vector Manufacturing Market in terms of revenue was estimated to be worth $5.5 billion in 2023 and is poised to reach $12.8 billion by 2028, growing at a CAGR of 18.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery. On the other hand, high operational cost associated with cell & gene therapy manufacturing is restraining the growth of this market. |
